Abstract
Objective:
To examine the effect of fish oil supplementation on duration of pregnancy, conditional on the woman's habitual fish intake.
Design:
Multicentre 1:1 randomised clinical trial of effect of fish oil in a high-risk population of pregnant women in whom habitual fish intake was assessed at randomisation.
Setting:
Nineteen university delivery wards in seven European countries.
Subjects:
Pregnant women with preterm delivery, intrauterine growth retardation (IUGR), or pregnancy-induced hypertension (PIH) in a previous pregnancy (group 1, n=495); with twin pregnancies (group 2, n=367); or with suspicion of IUGR or threatening preeclampsia in the current pregnancy (group 3, n=106). Women were stratified into low, middle, or high fish consumers.
Methods:
The intervention group received fish oil capsules providing 2.7 g long-chain n-3 fatty acids per day (n-3 poly unsaturated fatty acids (PUFA)) from around week 20 (groups 1 and 2) or 6.3 g n-3 PUFA from week 33 (group 3). The control regimen was capsules with olive oil. Effect on timing of spontaneous delivery was examined by Cox regression, assuming elective delivery (occurring in 40%) as a censoring event. Analyses of effect of fish oil were intention to treat, and all analyses were adjusted for maternal smoking, age, and parity.
Results:
In group 1, fish oil reduced the hazard rate of spontaneous delivery (HR) by 44% (95% confidence interval 14–64%) and 39% (16–56%) in low and middle fish consumers, respectively, with no detectable effect (−56 to 33%) in high fish consumers. In groups 2 and 3, no significant effect of fish oil was detected in any of the sub-strata defined by baseline fish consumption.
Conclusions:
In pregnant women with previous pregnancy complications, fish oil supplementation delayed onset of delivery in low and middle, but not in high, fish consumers.
Sponsorship:
March of Dimes Birth Defects Foundation, Concerted Action (ERB-BMH1-CT92-1906) and PECO (ERB-CIPD-CT94-0235) programmes of the European Commission, and the Danish National Research Foundation. Lube Ltd donated the oil capsules.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evidence based recommendations for an optimal prenatal supplement for women in the US: vitamins and related nutrients
Maternal Health, Neonatology and Perinatology Open Access 11 July 2022
-
Maternal intake of seafood and supplementary long chain n-3 poly-unsaturated fatty acids and preterm delivery
BMC Pregnancy and Childbirth Open Access 19 January 2017
-
Human placental transcriptome shows sexually dimorphic gene expression and responsiveness to maternal dietary n-3 long-chain polyunsaturated fatty acid intervention during pregnancy
BMC Genomics Open Access 27 October 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout



References
Baguma-Nibasheka M, Brenna JT, Nathanielsz PW (1999). Delay of preterm delivery in sheep by omega-3 long-chain polyunsaturates. Biol Reprod 60, 698–701.
Bjerregaard P, Hansen JC (1996). Effects of smoking and marine diet on birthweight in Greenland. Arctic Med Res 55, 156–164.
Bulstra-Ramakers MT, Huisjes HJ, Visser GH (1995). The effects of 3 g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 102, 123–126.
Eriksen PS, Secher NJ, Weis-Bentzon M (1985). Normal growth of the fetal biparietal diameter and the abdominal diameter in a longitudinal study. An evaluation of the two parameters in predicting fetal weight. Acta Obstet Gynecol Scand 64, 65–70.
Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T et al. (2001). Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108, E82.
Khoury J, Henriksen T, Christophersen B, Tonstad S (2005). Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial. Am J Obstet Gynecol 193, 1292–1301.
Knudsen VK, Hansen HS, Østerdal ML, Mikkelsen TB, Mu H, Olsen SF (2006). Fish oil in various doses and flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial. Br J Obstet Gynaecol 113, 536–543.
Makrides M, Duley L, Olsen S (2006). Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 3, CD003402.
Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW (2004). Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am J Epidemiol 160, 774–783.
Olsen SF (1994). Further on the association between retarded foetal growth and adult cardiovascular diease. Could low intake of marine diets be a common cause? J Clin Epidemiol 47, 565–569.
Olsen SF (2004). Is supplementation with marine omega-3 fatty acids during pregnancy a useful tool in the prevention of preterm birth? Clin Obstet Gynecol 47, 768–774.
Olsen SF, Hansen HS, Secher NJ, Jensen B, Sandström B (1995). Gestation length and birth weight in relation to intake of marine n-3 fatty acids. Br J Nutr 73, 397–404.
Olsen SF, Hansen HS, Sommer S, Jensen B, Sørensen TIA, Secher NJ et al. (1991). Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islands and Denmark. Am J Obstet Gynecol 164, 1203–1209.
Olsen SF, Hansen HS, Sorensen TI, Jensen B, Secher NJ, Sommer S et al. (1986). Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 2, 367–369.
Olsen SF, Mikkelsen TB, Knudsen VK, Orozova-Bekkevold I, Halldorsson TI, Strom M et al. (2006). Data collected on maternal dietary exposures in the Danish National Birth Cohort. Paediatr Perinat Epidemiol (in press).
Olsen SF, Secher NJ (2002). Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ 324, 447.
Olsen SF, Secher NJ, Bjornsson S, Weber T, Atke A (2003). The potential benefits of using fish oil in relation to preterm labor: the case for a randomized controlled trial? Acta Obstet Gynecol Scand 82, 978–982.
Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C (2000). Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. Br J Obstet Gynaecol 107, 382–395.
Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS et al. (1992). Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339, 1003–1007.
Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D (1995). A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 102, 95–100.
Rogers I, Emmett P, Ness A, Golding J (2004). Maternal fish intake in late pregnancy and the frequency of low birth weight and intrauterine growth retardation in a cohort of British infants. J Epidemiol Commun Health 58, 486–492.
Secher NJ, Hansen PK, Lenstrup C, Pedersen-Bjergaard L, Eriksen PS, Thomsen BL et al. (1986). Birthweight-for-gestational age charts based on early ultrasound estimation of gestational age. Br J Obstet Gynaecol 93, 128–134.
Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE (2003). A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 101, 469–479.
Szajewska H, Horvath A, Koletzko B (2006). Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 83, 1337–1344.
Thorsdottir I, Birgisdottir BE, Halldorsdottir S, Geirsson RT (2004). Association of fish and fish liver oil intake in pregnancy with infant size at birth among women of normal weight before pregnancy in a fishing community. Am J Epidemiol 160, 460–465.
Acknowledgements
The study was funded by March of Dimes Birth Defects Foundation, Concerted Action (ERB-BMH1-CT92-1906), and PECO (ERB-CIPD-CT94-0235) programmes of the European Commission, and the Danish National Research Foundation. Lube Ltd provided Pikasol fish oil and olive oil capsules. The FOTIP Team is described in British Journal of Obstetrics and Gynaecology 2000; 107: 382–395.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Olsen, S., Østerdal, M., Salvig, J. et al. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur J Clin Nutr 61, 976–985 (2007). https://doi.org/10.1038/sj.ejcn.1602609
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602609
Keywords
- fish oil
- fish intake
- pregnancy duration
- RCT
This article is cited by
-
Evidence based recommendations for an optimal prenatal supplement for women in the US: vitamins and related nutrients
Maternal Health, Neonatology and Perinatology (2022)
-
An analysis of omega-3 fatty acid status in a population of pregnant women with obesity, at higher risk of preterm birth
European Journal of Clinical Nutrition (2020)
-
Ernährung und Nahrungsergänzungsmittel bei Kinderwunsch der Frau
Gynäkologische Endokrinologie (2019)
-
Maternal intake of seafood and supplementary long chain n-3 poly-unsaturated fatty acids and preterm delivery
BMC Pregnancy and Childbirth (2017)
-
Human placental transcriptome shows sexually dimorphic gene expression and responsiveness to maternal dietary n-3 long-chain polyunsaturated fatty acid intervention during pregnancy
BMC Genomics (2014)